HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simon Ducharme Selected Research

Simon Ducharme Research Topics

Disease

29Frontotemporal Dementia (Semantic Dementia)
04/2024 - 01/2018
9Disease Progression
05/2024 - 12/2019
9Alzheimer Disease (Alzheimer's Disease)
12/2023 - 07/2013
7Atrophy
01/2024 - 01/2018
5Dementia (Dementias)
05/2024 - 07/2013
5Mental Disorders (Mental Disorder)
03/2024 - 01/2019
3Cognitive Dysfunction
05/2024 - 01/2019
3Parkinson Disease (Parkinson's Disease)
01/2024 - 01/2011
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
12/2023 - 01/2022
2Gliosis
01/2022 - 01/2020
2Psychotic Disorders (Schizoaffective Disorder)
06/2019 - 01/2017
1Prodromal Symptoms
01/2023
1Sleep Apnea Syndromes (Sleep Apnea)
10/2022
1Neuroinflammatory Diseases
09/2022
1Tauopathies
01/2022
1COVID-19
01/2022
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2022
1Cerebral Cortical Thinning
01/2021
1Neurocognitive Disorders (Clerambault Syndrome)
01/2021
1Kufor-Rakeb syndrome
06/2019
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2019
1Nervous System Diseases (Neurological Disorders)
01/2019
1Major Depressive Disorder (Major Depressive Disorders)
01/2019
1Seizures (Absence Seizure)
01/2017
1Status Epilepticus (Complex Partial Status Epilepticus)
01/2017
1Epilepsy (Aura)
01/2017
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
07/2013
1Opioid-Related Disorders (Opiate Addiction)
01/2012
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2012

Drug/Important Bio-Agent (IBA)

24Biomarkers (Surrogate Marker)IBA
05/2024 - 01/2012
4Tuberculin (PPD)IBA
03/2024 - 01/2019
4ProgranulinsIBA
01/2023 - 01/2019
4GranulinsIBA
01/2022 - 01/2021
3Amyloid (Amyloid Fibrils)IBA
05/2024 - 07/2013
3Proteins (Proteins, Gene)FDA Link
11/2023 - 11/2021
2Indicators and Reagents (Reagents)IBA
05/2024 - 01/2024
2TabletsIBA
01/2024 - 01/2023
2Antisense OligonucleotidesIBA
10/2023 - 06/2023
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2023 - 08/2022
2Complement System Proteins (Complement)IBA
09/2022 - 01/2020
2Glial Fibrillary Acidic ProteinIBA
01/2022 - 01/2020
2neuronal pentraxinIBA
01/2022 - 01/2020
12- (3,4- dichlorophenyl)- N- methyl- N- (1- (3- isothiocyanatophenyl)- 2- (1- pyrrolidinyl)ethyl)acetamideIBA
12/2023
1Blood Proteins (Serum Proteins)IBA
11/2023
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2023
1Dopamine (Intropin)FDA LinkGeneric
01/2023
1Serotonin (5 Hydroxytryptamine)IBA
01/2023
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2023
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022
1SuspensionsIBA
11/2021
1Aripiprazole (Abilify)FDA Link
06/2019
1Protons (Proton)IBA
01/2018
1Antipsychotic Agents (Antipsychotics)IBA
01/2017
1Clozapine (Clozaril)FDA LinkGeneric
01/2017
12- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
07/2013
1Naloxone Drug Combination BuprenorphineFDA Link
01/2012
1Buprenorphine (Subutex)FDA LinkGeneric
01/2012

Therapy/Procedure

2Deep Brain Stimulation
01/2019 - 01/2011
1Neurosurgical Procedures
01/2019